Autori: Xu Li-An
| Naslov | A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate (Article) |
| Autori | Mease P Strand Vibeke Shalamberidze L Dimic Aleksandar N Raskina T Xu Li-An Liu Y Smith J |
| Info | ANNALS OF THE RHEUMATIC DISEASES, (2012), vol. 71 br. 7, str. 1183-1189 |
| Projekat | Alder Biopharmaceuticals; Bristol-Myers Squibb; Abbott; Amgen; BiogenIdec; Centocor; Genentech; Lilly; Pfizer; UCB |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
     |
